Risk factors and management of breast lymphoedema after breast-conserving treatment: a scoping review
Clinical Breast Cancer · 2026-11
DOI: 10.1016/j.clbc.2026.10.018 ↗Kurz gefasst
Scoping Review in der Zeitschrift Clinical Breast Cancer, 2026-11. Verfasst von Julia Severin und 3 weiteren Autor:innen. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Breast lymphoedema is poorly understood adverse effect of breast-conserving treatment (BCT) and is often underdiagnosed. Symptoms of breast lymphoedema can significantly affect quality of life, however it is often underdiagnosed in clinical practice. Reported incidence varies from 0-94%, likely due to a lack of universally accepted diagnostic criteria. This scoping review aimed to characterise the literature regarding risk factors of breast lymphoedema and explore current evidence around management options.
Methods
The study was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR) guidelines. Databases searched were PubMed, Medline, Embase, and Google Scholar, including papers published between 1 st January 2010 – 4 th June 2025. 39 manuscripts were included in the final analysis.
Results
The main risk factors identified in this review were larger breast volume, high BMI, higher breast density, diabetes mellitus, larger tumour size, post-operative infection, increased breast separation, and use of conventional fractionation radiation therapy. Current evidence supports complex decongestive therapy (CDT), exercise alone or in combination with manual lymphatic drainage (MLD), and surgical techniques such as lymphaticovenous anastomosis (LVA) or vascularized lymph node transplant (VLNT) for the management of breast lymphoedema.
Conclusion
Management of breast lymphoedema is understudied. A variety of risk factors have been associated with the development of breast lymphoedema, however many of them are supported by weak or conflicting evidence. Many of these risk factors require further investigation with more robust methodology.
Zitieren
APA
Severin, J., Ayeni, F. E., Gysen, K. V., & Edirimanne, S. (2026). Risk factors and management of breast lymphoedema after breast-conserving treatment: a scoping review. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2026.10.018
Vancouver
Severin J, Ayeni FE, Gysen KV, Edirimanne S. Risk factors and management of breast lymphoedema after breast-conserving treatment: a scoping review. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2026.10.018
BibTeX
@article{Severin2026,
author = {Severin, Julia and Ayeni, Femi E. and Gysen, Kirsten Van and Edirimanne, Senarath},
title = {Risk factors and management of breast lymphoedema after breast-conserving treatment: a scoping review},
journal = {Clinical Breast Cancer},
year = {2026},
doi = {10.1016/j.clbc.2026.10.018}
}
EUVIMED